Histone deacetylases 10 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer

doi:10.3748/wjg.v31.i26.108662

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (639)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

HTML

419

Figures (1-7)

Sum=496

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=105

Jul 14, 2025 (publication date) through Jul 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jul 14, 2025; 31(26): 108662
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.108662

Full Size Figure Download Figure

Figure 7 Immunotherapy and drug sensitivity analysis. A-H: Low immunotherapy response in high histone deacetylases 10 (HDAC10) group from Gide 2019, GSE53127, GSE91061, GSE100797, GSE103668, GSE111636, GSE126044, and IMvigor210 cohorts; I-P: Low common chemotherapy drug sensitivity in high HDAC10 group. HDAC10: Histone deacetylases 10.

Citation: Nie HH, Yang XY, Zhou JK, Gao GL, Ding L, Hong YT, Yu YL, Qiu PS, Zeng ZY, Lai J, Zheng T, Wang HZ, Zhao Q, Wang F. Histone deacetylases 10 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer. World J Gastroenterol 2025; 31(26): 108662
URL: https://www.wjgnet.com/1007-9327/full/v31/i26/108662.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i26.108662